BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dashtbani-Roozbehani A, Brown MH. Efflux Pump Mediated Antimicrobial Resistance by Staphylococci in Health-Related Environments: Challenges and the Quest for Inhibition. Antibiotics (Basel) 2021;10:1502. [PMID: 34943714 DOI: 10.3390/antibiotics10121502] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Rampacci E, Felicetti T, Pietrella D, Sabatini S, Passamonti F. Drug efflux transporters in Staphylococcus pseudintermedius: in silico prediction and characterization of resistance. J Antimicrob Chemother 2022:dkac314. [PMID: 36173389 DOI: 10.1093/jac/dkac314] [Reference Citation Analysis]
2 Hayward C, Brown MH, Whiley H. Hospital water as the source of healthcare-associated infection and antimicrobial-resistant organisms. Curr Opin Infect Dis 2022;35:339-45. [PMID: 35849524 DOI: 10.1097/QCO.0000000000000842] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Majumder P, Ahmed S, Ahuja P, Athreya A, Ranjan R, Penmatsa A. CryoEM structure of QacA, an antibacterial efflux transporter from Staphylococcus aureus.. [DOI: 10.1101/2022.07.09.499445] [Reference Citation Analysis]
4 Ashraf S, Parrine D, Bilal M, Chaudhry U, Lefsrud M, Zhao X. Proteomic Comparison of Ivermectin Sensitive and Resistant Staphylococcus aureus Clinical Isolates Reveals Key Efflux Pumps as Possible Resistance Determinants. Antibiotics 2022;11:759. [DOI: 10.3390/antibiotics11060759] [Reference Citation Analysis]
5 Cai Z, Chen B, Yu Y, Guo J, Luo Z, Cheng B, Xu J, Gu Q, Zhou H. Design, Synthesis, and Proof-of-Concept of Triple-Site Inhibitors against Aminoacyl-tRNA Synthetases. J Med Chem 2022. [PMID: 35363470 DOI: 10.1021/acs.jmedchem.2c00134] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Nefedova E, Shkil N, Luna Vazquez-gomez R, Garibo D, Pestryakov A, Bogdanchikova N. AgNPs Targeting the Drug Resistance Problem of Staphylococcus aureus: Susceptibility to Antibiotics and Efflux Effect. Pharmaceutics 2022;14:763. [DOI: 10.3390/pharmaceutics14040763] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Penmatsa A. A (Fab)ulous tool to block efflux. Nat Chem Biol 2022. [PMID: 35361991 DOI: 10.1038/s41589-022-00999-4] [Reference Citation Analysis]
8 Jampilek J, Kralova K. Advances in Nanostructures for Antimicrobial Therapy. Materials (Basel) 2022;15:2388. [PMID: 35407720 DOI: 10.3390/ma15072388] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]